Clinical Trial Update: Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing safety and potential efficacy of SC101 delivered via perirenal fat injection for resistant hypertension in patients with chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Resistant Hypertension

Drugs mentioned

• SC101

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Resistant Arterial Hypertension, Chronic Kidney Disease (Stage 3-4) | Phase 1 | Status: RECRUITING